Background Several creatinine-and cystatin-C–based indices have been proposed as
sarcopenia predictors. This study aimed to compare serum creatinine-and cystatin-C–based …

Aims Sarcopenia, the age‐related decline in skeletal muscle volume and function, is
associated with negative clinical and socioeconomic outcomes in elderly people. Clinical …

The aim of this study was to evaluate the diagnostic value of the sarcopenia index (serum
creatinine [mg/dl]/cystatin C [mg/dl]× 100) for estimating low muscle mass and sarcopenia in …

Purpose Considering the clinical impact of sarcopenia, it would be interesting to get a rapid
and sensible screening tool. We conducted a cross-sectional study with the motive to use an …

Background The sarcopenia index (SI, serum creatinine/serum cystatin C× 100) is
recommended for predicting sarcopenia. There were several studies showing that lower SI …

Purpose To investigate the association of sarcopenia index (SI)[(serum creatinine/serum
cystatin C)× 100] with mortality, nutritional risk/malnutrition and sarcopenia among …

Aim The serum creatinine/cystatin C ratio (CCR) or sarcopenia index is considered a useful
marker of muscle mass. However, its usefulness in late‐stage older adults remains unclear …

To investigate the association of the sarcopenia index (SI, serum creatinine value/cystatin C
value× 100) with 3-year mortality and readmission among older inpatients, we reanalyzed a …

Objective Sarcopenia is a prevalent condition in the senior population and has been related
to adverse outcomes. This study aimed to investigate the performance of the serum …

Background Sarcopenia is an important prognostic factor, but its optimal screening methods
remain challenging. Several new indices developed based on serum creatinine (Cr) and …